Skip to main content
Erschienen in: Heart and Vessels 10/2016

11.12.2015 | Original Article

Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease

verfasst von: Michael Sponder, Monika Fritzer-Szekeres, Rodrig Marculescu, Brigitte Litschauer, Jeanette Strametz-Juranek

Erschienen in: Heart and Vessels | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

The balance between the angiostatic factor endostatin (ES) and angiogenic factor osteopontin (OPN) is essential in physiological and pathological angiogenesis. Several circumstances might influence this equilibrium and are of distinct interest when investigating mechanisms in coronary artery disease (CAD). The present explorative cross-sectional study was to investigate the influence of physical inactivity on ES and OPN levels in 181 male and 71 female patients with angiographycally verified CAD. Anamnestic and laboratory data were collected; ES was measured in serum and OPN in plasma by ELISA. Univariate analysis of variance was used to test for the influence of physical activity on ES and OPN levels and age, BMI, sex and diabetes status were included as covariates. ES and OPN intercorrelated significantly (r = 0.42; p < 0.001). ES and OPN decreased significantly in response to increasing activity level of patients suffering CAD (F = 5.5; p < 0.001 and F = 3.6; p < 0.01 resp.). This study is the first to show a linear decrease in ES and OPN levels in CAD patients depending on the degree of physical activity undergone. Lower levels of ES and OPN in physically active patients might be a sign of increased angiogenesis and decreased inflammation and calcifying activity and therefore contribute to the understanding of the damaging effect of physical inactivity in cardiovascular disease.
Literatur
1.
Zurück zum Zitat Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J (2014) A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity. Vasc Health Risk Manag 10:641–647CrossRefPubMedPubMedCentral Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J (2014) A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity. Vasc Health Risk Manag 10:641–647CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277–285CrossRefPubMed O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277–285CrossRefPubMed
3.
Zurück zum Zitat Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18(16):4414–4423CrossRefPubMedPubMedCentral Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18(16):4414–4423CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Cho H, Kim WJ, Lee YM, Kim YM, Kwon YG, Park YS, Choi EY, Kim KW (2004) N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent. Oncol Rep 11(1):191–195PubMed Cho H, Kim WJ, Lee YM, Kim YM, Kwon YG, Park YS, Choi EY, Kim KW (2004) N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent. Oncol Rep 11(1):191–195PubMed
5.
Zurück zum Zitat Mitsuma W, Kodama M, Hanawa H, Ito M, Ramadan MM, Hirono S, Obata H, Okada S, Sanada F, Yanagawa T, Kashimura T, Fuse K, Tanabe N, Aizawa Y (2007) Serum endostatin in the coronary circulation of patients with coronary heart disease and its relation to coronary collateral formation. Am J Cardiol 99(4):494–498CrossRefPubMed Mitsuma W, Kodama M, Hanawa H, Ito M, Ramadan MM, Hirono S, Obata H, Okada S, Sanada F, Yanagawa T, Kashimura T, Fuse K, Tanabe N, Aizawa Y (2007) Serum endostatin in the coronary circulation of patients with coronary heart disease and its relation to coronary collateral formation. Am J Cardiol 99(4):494–498CrossRefPubMed
6.
Zurück zum Zitat Sponder M, Fritzer-Szekeres M, Litschauer B, Binder T, Strametz-Juranek J (2015) Endostatin and osteopontin are elevated in patients with both coronary artery disease and aortic valve calcification. IJC Metab Endocr 9:5–9CrossRef Sponder M, Fritzer-Szekeres M, Litschauer B, Binder T, Strametz-Juranek J (2015) Endostatin and osteopontin are elevated in patients with both coronary artery disease and aortic valve calcification. IJC Metab Endocr 9:5–9CrossRef
7.
Zurück zum Zitat Sodha NR, Clements RT, Boodhwani M, Xu SH, Laham RJ, Bianchi C, Sellke FW (2009) Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 296(2):H428–H434CrossRefPubMed Sodha NR, Clements RT, Boodhwani M, Xu SH, Laham RJ, Bianchi C, Sellke FW (2009) Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 296(2):H428–H434CrossRefPubMed
8.
Zurück zum Zitat Sponder M, Dangl D, Kampf S, Fritzer-Szekeres M, Strametz-Juranek J (2014) Exercise increases serum endostatin levels in female and male patients with diabetes and controls. Cardiovasc Diabetol 13(1):6CrossRefPubMedPubMedCentral Sponder M, Dangl D, Kampf S, Fritzer-Szekeres M, Strametz-Juranek J (2014) Exercise increases serum endostatin levels in female and male patients with diabetes and controls. Cardiovasc Diabetol 13(1):6CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Sponder M, Sepiol K, Lankisch S, Priglinger M, Kampf S, Litschauer B, Fritzer-Szekeres M, Strametz-Juranek J (2014) Endostatin and physical exercise in young female and male athletes and controls. Int J Sports Med 35(13):1138–1142CrossRefPubMed Sponder M, Sepiol K, Lankisch S, Priglinger M, Kampf S, Litschauer B, Fritzer-Szekeres M, Strametz-Juranek J (2014) Endostatin and physical exercise in young female and male athletes and controls. Int J Sports Med 35(13):1138–1142CrossRefPubMed
10.
Zurück zum Zitat Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y (2009) Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 28(38):3412–3422CrossRefPubMed Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y (2009) Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 28(38):3412–3422CrossRefPubMed
11.
Zurück zum Zitat Zhao X, Johnson JN, Singh K, Singh M (2007) Impairment of myocardial angiogenic response in the absence of osteopontin. Microcirculation 14(3):233–240CrossRefPubMed Zhao X, Johnson JN, Singh K, Singh M (2007) Impairment of myocardial angiogenic response in the absence of osteopontin. Microcirculation 14(3):233–240CrossRefPubMed
12.
Zurück zum Zitat Zhang YL, Zhou SX, Lei J, Yuan GY, Wang JF (2008) Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction. Chin Med J (Engl) 121(21):2192–2196 Zhang YL, Zhou SX, Lei J, Yuan GY, Wang JF (2008) Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction. Chin Med J (Engl) 121(21):2192–2196
13.
Zurück zum Zitat Kahles F, Findeisen HM, Bruemmer D (2014) Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab 3(4):384–393CrossRefPubMedPubMedCentral Kahles F, Findeisen HM, Bruemmer D (2014) Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab 3(4):384–393CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Okyay K, Tavil Y, Sahinarslan A, Tacoy G, Turfan M, Sen N, Gurbahar O, Boyaci B, Yalcin R, Demirkan D, Cengel A (2014) Plasma osteopontin levels in prediction of prognosis in acute myocardial infarction. Acta Cardiol 66(2):197–202 Okyay K, Tavil Y, Sahinarslan A, Tacoy G, Turfan M, Sen N, Gurbahar O, Boyaci B, Yalcin R, Demirkan D, Cengel A (2014) Plasma osteopontin levels in prediction of prognosis in acute myocardial infarction. Acta Cardiol 66(2):197–202
15.
Zurück zum Zitat Abdel-Azeez HA, Al-Zaky M (2010) Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis. J Clin Lab Anal 24(3):201–206CrossRefPubMed Abdel-Azeez HA, Al-Zaky M (2010) Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis. J Clin Lab Anal 24(3):201–206CrossRefPubMed
16.
Zurück zum Zitat Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F (2003) Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170(2):333–337CrossRefPubMed Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F (2003) Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170(2):333–337CrossRefPubMed
17.
Zurück zum Zitat Mazzone A, Parri MS, Giannessi D, Ravani M, Vaghetti M, Altieri P, Casalino L, Maltinti M, Balbi M, Barsotti A, Berti S (2011) Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study. Coron Artery Dis 22(3):179–187CrossRefPubMed Mazzone A, Parri MS, Giannessi D, Ravani M, Vaghetti M, Altieri P, Casalino L, Maltinti M, Balbi M, Barsotti A, Berti S (2011) Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study. Coron Artery Dis 22(3):179–187CrossRefPubMed
18.
Zurück zum Zitat Cho HJ, Kim HS (2009) Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 11(3):206–213CrossRefPubMed Cho HJ, Kim HS (2009) Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 11(3):206–213CrossRefPubMed
19.
Zurück zum Zitat Kurose S, Iwasaka J, Tsutsumi H, Yamanaka Y, Shinno H, Fukushima Y, Higurashi K, Imai M, Masuda I, Takeda S, Kawai C, Kimura Y (2015) Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome. Heart Vessels. doi:10.1007/s00380-015-0681-1 PubMed Kurose S, Iwasaka J, Tsutsumi H, Yamanaka Y, Shinno H, Fukushima Y, Higurashi K, Imai M, Masuda I, Takeda S, Kawai C, Kimura Y (2015) Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome. Heart Vessels. doi:10.​1007/​s00380-015-0681-1 PubMed
20.
Zurück zum Zitat Talbot LA, Morrell CH, Fleg JL, Metter EJ (2007) Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore longitudinal study of aging. Prev Med 45(2–3):169–176CrossRefPubMed Talbot LA, Morrell CH, Fleg JL, Metter EJ (2007) Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore longitudinal study of aging. Prev Med 45(2–3):169–176CrossRefPubMed
21.
Zurück zum Zitat Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN (2008) Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 15(3):239–246CrossRefPubMed Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN (2008) Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 15(3):239–246CrossRefPubMed
22.
Zurück zum Zitat Lollgen H, Bockenhoff A, Knapp G (2009) Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med 30(3):213–224CrossRefPubMed Lollgen H, Bockenhoff A, Knapp G (2009) Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med 30(3):213–224CrossRefPubMed
23.
Zurück zum Zitat Mora S, Cook N, Buring JE, Ridker PM, Lee IM (2007) Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 116(19):2110–2118CrossRefPubMedPubMedCentral Mora S, Cook N, Buring JE, Ridker PM, Lee IM (2007) Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 116(19):2110–2118CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Smith TC, Wingard DL, Smith B, Kritz-Silverstein D, Barrett-Connor E (2007) Walking decreased risk of cardiovascular disease mortality in older adults with diabetes. J Clin Epidemiol 60(3):309–317CrossRefPubMed Smith TC, Wingard DL, Smith B, Kritz-Silverstein D, Barrett-Connor E (2007) Walking decreased risk of cardiovascular disease mortality in older adults with diabetes. J Clin Epidemiol 60(3):309–317CrossRefPubMed
25.
Zurück zum Zitat Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G (2000) Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342(7):454–460CrossRefPubMed Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G (2000) Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342(7):454–460CrossRefPubMed
26.
Zurück zum Zitat Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, Nickenig G (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109(2):220–226CrossRefPubMed Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, Nickenig G (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109(2):220–226CrossRefPubMed
27.
Zurück zum Zitat Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, Eder JP Jr, Folkman J, Soker S (2003) Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 63(23):8345–8350PubMed Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, Eder JP Jr, Folkman J, Soker S (2003) Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 63(23):8345–8350PubMed
28.
Zurück zum Zitat Jin X, Fu GX, Li XD, Zhu DL, Gao PJ (2011) Expression and function of osteopontin in vascular adventitial fibroblasts and pathological vascular remodeling. PLoS One 6(9):e23558CrossRefPubMedPubMedCentral Jin X, Fu GX, Li XD, Zhu DL, Gao PJ (2011) Expression and function of osteopontin in vascular adventitial fibroblasts and pathological vascular remodeling. PLoS One 6(9):e23558CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Shiroma EJ, Lee IM (2010) Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation 122(7):743–752CrossRefPubMed Shiroma EJ, Lee IM (2010) Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation 122(7):743–752CrossRefPubMed
30.
Zurück zum Zitat Brixius K, Schoenberger S, Ladage D, Knigge H, Falkowski G, Hellmich M, Graf C, Latsch J, Montie GL, Prede GL, Bloch W (2008) Long-term endurance exercise decreases antiangiogenic endostatin signalling in overweight men aged 50–60 years. Br J Sports Med 42(2):126–129 (discussion 129) Brixius K, Schoenberger S, Ladage D, Knigge H, Falkowski G, Hellmich M, Graf C, Latsch J, Montie GL, Prede GL, Bloch W (2008) Long-term endurance exercise decreases antiangiogenic endostatin signalling in overweight men aged 50–60 years. Br J Sports Med 42(2):126–129 (discussion 129)
31.
Zurück zum Zitat You JS, Ji HI, Chang KJ, Yoo MC, Yang HI, Jeong IK, Kim KS (2013) Serum osteopontin concentration is decreased by exercise-induced fat loss but is not correlated with body fat percentage in obese humans. Mol Med Rep 8(2):579–584PubMed You JS, Ji HI, Chang KJ, Yoo MC, Yang HI, Jeong IK, Kim KS (2013) Serum osteopontin concentration is decreased by exercise-induced fat loss but is not correlated with body fat percentage in obese humans. Mol Med Rep 8(2):579–584PubMed
32.
Zurück zum Zitat Zhu H, Jiang X, Li X, Hu M, Wan W, Wen Y, He Y, Zheng X (2015) Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction. Heart Vessels. doi:10.1007/s00380-015-0710-0 Zhu H, Jiang X, Li X, Hu M, Wan W, Wen Y, He Y, Zheng X (2015) Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction. Heart Vessels. doi:10.​1007/​s00380-015-0710-0
33.
Zurück zum Zitat Panchal VR, Rehman J, Nguyen AT, Brown JW, Turrentine MW, Mahomed Y, March KL (2004) Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. J Am Coll Cardiol 43(8):1383–1387CrossRefPubMed Panchal VR, Rehman J, Nguyen AT, Brown JW, Turrentine MW, Mahomed Y, March KL (2004) Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. J Am Coll Cardiol 43(8):1383–1387CrossRefPubMed
34.
Zurück zum Zitat Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H (2005) Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 96(7):717–722CrossRefPubMed Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H (2005) Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 96(7):717–722CrossRefPubMed
Metadaten
Titel
Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease
verfasst von
Michael Sponder
Monika Fritzer-Szekeres
Rodrig Marculescu
Brigitte Litschauer
Jeanette Strametz-Juranek
Publikationsdatum
11.12.2015
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 10/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0778-6

Weitere Artikel der Ausgabe 10/2016

Heart and Vessels 10/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.